Helicobacter Pylori Diagnostics Market, by Test Type (Invasive (Immunoassay, Rapid Urease Test and Histology) and Non-invasive (Stool Antigen Assay, Serology Tests and Urea Breath Test)), by End Users (Hospitals, Clinics, Diagnostic Laboratories and Others) and by Region - Global Forecast to 2026

  • Published On : Jun 2018 |
  • Pages : 167 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Helicobacter Pylori Diagnostics Market Insights – Quick Tests Allowing Efficient Diagnosis

Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six individuals infected with H. pylori are expected to eventually develop peptic ulcer disease. Infected individuals experience long asymptomatic conditions with nearly 70% of individuals having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc. Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which are obtained through endoscopy and used for biopsy or non-invasive tests that requires blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas non-invasive includes stool antigen assays serology tests and urea breath test.

The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

  Figure 1. Global Helicobacter Pylori Diagnostics Market Share, By Test Type

Helicobacter Pylori Diagnostics  | Coherent Market Insights

Source: Coherent Market Insights (2018)

Increasing prevalence of helicobacter pylori in emerging economies is propelling the Helicobacter pylori diagnostics market growth

Prevalence of helicobacter pylori is declining in developed countries, whereas its prevalence in emerging economies is increasing. For instance, according to the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), 2017, around 4.4 billion people worldwide are infected with Helicobacter pylori (H. pylori). Furthermore, same source suggested that prevalence in Africa is up to 80%, which is the highest globally, while in Asia, over 50% of the population was infected with H. pylori. Moreover, according to the International Agency for Research on Cancer report 2014, in 2012, around 952,000 new gastric cancer cases occurred globally and around 734,000 gastric cancers were estimated to occur due to H. pylori infection. Such high prevalence of Helicobacter pylori in Africa and Asia is expected to fuel the regional helicobacter market growth.

The limitations associated with diagnostic tests are expected to be a major factor restraining growth of the Helicobacter pylori diagnostics market. For instance, serology-based assays have low sensitivity and specificity, as they are unable to differentiate between active infection and IgG antibodies present in case of post treatment.

Africa market to exhibit fastest growth over the forecast period

Regionally, Helicobacter pylori diagnostics market is segmented into - North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America Helicobacter pylori diagnostic market holds dominant position in the global market and this is attributed to initiatives to provide test kits at low costs to eradicate H. pylori infection. For instance, antibody-based detection tests are available at lower cost for enhancing the eradication of helicobacter pylori infection in Quebec. Moreover, Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), an independent body reporting to the Quebec Minister of Health and Social Services, recommends the 13C-urea breath test to be made available in all areas of Québec. However, Africa Helicobacter pylori diagnostic market is expected to exhibit high CAGR, owing to high prevalence of Helicobacter pylori. According to studies published in Gastroenterology Journal, 2017, the data suggested that Africa has highest prevalence of H. pylori infection, which is around 79%.

Inorganic strategies by key players is fuelling growth of the Helicobacter pylori diagnostics market

Key players involved in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.

Manufacturers are focusing on inorganic strategies, in order to enhance their product offerings. For instance, Diasorin S.P.A., in September 2017, acquired ELISA technology business from Siemens, with an aim of shifting the current client base that uses ELISA tests towards CLIA technology solutions. As a part of agreement, Siemens will continue to manufacture and supply ELISA immunodiagnostic kits exclusively for DiaSorin for the next three years.

Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-of-care testing are major factors driving growth of Helicobacter pylori diagnostics market.

Market Dynamics

Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment.

Key features of the study:

  • This report provides in-depth analysis of the Helicobacter pylori diagnostics market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, product recalls, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global helicobacter pylori diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.
  • The global Helicobacter pylori diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of helicobacter pylori diagnostic tests/devices, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the Helicobacter pylori diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Helicobacter Pylori Diagnostics Market, By Test Type:
    • Invasive
      • Immunoassay
      • Rapid Urease Test
      • Histology
    • Non-invasive
      • Stool Antigen Assays
      • Serology Tests
      • Urea Breath Test
    • Global Helicobacter Pylori Diagnostics Market, By End User:
      • Hospitals
      • Clinics
      • Diagnostic Laboratories
      • Others
  • Global Helicobacter Pylori Diagnostics Market, By Region:
    • North America Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • U.S.
          • Canada
    • Latin America Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • Brazil
          • Mexico
          • Argentina
          • Rest of Latin America
    • Europe Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • Germany
          • U.K.
          • Italy
          • France
          • Spain
          • Russia
          • Rest of Europe
    • Asia Pacific Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • China
          • India
          • Japan
          • ASEAN
          • Australia
          • South Korea
          • Rest of Asia Pacific
    • Middle East Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By Country:
          • GCC
          • Israel
          • Rest of Middle East
    • Africa Helicobacter Pylori Diagnostics Market
      • By Test Type:
        • Invasive
          • Immunoassay
          • Rapid Urease Test
          • Histology
        • Non-invasive
          • Stool Antigen Assays
          • Serology Tests
          • Urea Breath Test
        • By End User:
          • Hospitals
          • Clinics
          • Diagnostic Laboratories
          • Others
        • By country:
          • North Africa
          • Central Africa
          • South Africa
  • Company Profiles
    • Thermo Fisher Scientific, Inc.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategies
    • Bio-Rad Laboratories Inc.
    • Diasorin S.P.A.
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
    • Meridian Bioscience, Inc.
    • Exalenz Bioscience Ltd.
    • Abbott Laboratories
    • Cardinal Health, Inc.
    • Halyard Health, Inc.

Strategies “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Industry Trends
    • Epidemiology
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Helicobacter Pylori Diagnostics Market, By Test Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Invasive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2026, (US$ Million)
        • Immunoassay
        • Rapid Urease Test
        • Histology
    • Non-Invasive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2026, (US$ Million)
        • Stool Antigen Assays
        • Serology Tests
        • Urea Breath Test
  5. Global Helicobacter Pylori Diagnostics Market, By End User, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Diagnostics Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
  6. Global Helicobacter Pylori Diagnostics Market, By Regions, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2017 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Thermo Fisher Scientific, Inc.*
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Bio-Rad Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Diasorin S.P.A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Quidel Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Meridian Bioscience, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Exalenz Bioscience Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Cardinal Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Halyard Health, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 27 market data tables and 30 figures on “Helicobacter Pylori Diagnostics Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.